-
Samsung Galaxy Buds Active Leak Reveals ANC, Ear-Hook Design and One UI 9.5 Integration
-
Saudi PIF Retains Top Sovereign Wealth Fund Brand Title for Third Year
-
Egypt and Syria Sign Agreement to Restore Direct Flights After 14-Year Hiatus
-
Professor Shahida Moosa Pioneers Medical Genomics in South Africa Amid Testing Shortages
-
Van Gogh’s ‘Châtaigniers en Fleurs’ Sets $285m Record at Sotheby’s
-
Texas Marijuana Decriminalization Faces Uncertain Future Under New Attorney General
-
Anthropic Sets Record $81.3 Billion IPO Valuing AI Firm at $1.5 Trillion
-
Early Black Friday Laptop Deals: MacBook Neo, IdeaPad Slim 5x, and Surface Laptop Prices Drop
-
eThekwini Faces R6.5bn Flood Claim from Toyota’s Insurer
-
2026 East Bay Nosh Awards Voting Opens for Food and Drink Favorites
-
Helio Corporation Engages CORE IR to Provide Investor Relations, Capital Markets Advisory and Media Relations Services
-
The 2026 MDaudit Annual Benchmark Report Spotlights AI's Impact on Financial Risk as Payer Denials and Audits Continue an Upward Trajectory
-
Greene Concepts Connects Consumer Needs with Manufacturing Strategy
-
Karbon-X (OTCQB:KARX) Enters California's Multi-Billion-Dollar Compliance Carbon Market Following CITSS Approval
-
Skilled Nursing Facilities Face 2027 Revenue Cycle Reckoning as Payer Burdens Reshape Admissions and Outsourcing
-
Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
-
multiQure Begins Manufacturing Phase of MQ-201 Gene Therapy for First Huntington's Disease Patients - U.S.-Based Andelyn Biosciences Selected as Manufacturing Partner
-
Arrive AI Eliminates All Debt Through Preferred Equity Exchange
-
QNX Brings Physical AI and Next-Generation Software-Defined Vehicle Innovation to CES 2027
-
More Than Half of Teen AI Chatbot Users Use Them Daily, and 46% Say It Feels Like Talking to a Human, New Family Online Safety Institute Research Finds
-
MicroVision and Blue-Band to Support $3 Million Federally Funded Intelligent Transportation Initiative in Louisville, Kentucky
-
Stemtech Corporation Partners with Fitness Icon Tony Little to Launch Stemtech Biosciences Digital Campaign
-
Guanajuato Silver Reports Q3 Operating and Financial Results
-
Golden Minerals Completes Drilling Desierto, Argentina
-
Gamma Resources Announces Expansion of Mesa Arc Uranium Project in New Mexico to 4,760 Acres, Completes Radon Flux Baseline Survey
-
Trustpoint Xposure Completes More Than 200 AI Visibility Audits Across Professional Services
-
NoHo, Inc. Acquires Four Placer Gold Claims in Clark County, Nevada from Gold Stake Mining Inc.
-
IRS Shuts Down FIRE Today: What Information Return Filers Need to Know Before the 2027 Filing Season
-
First Canadian Graphite Reports 43.9% Graphitic Carbon Sample and Encouraging Coarse-Flake Characteristics at Zone 13 at Lac Guéret South
-
LASE to Premiere Quantum Bullet(TM) at Counter UAS Technology Conference in Washington, D.C.
-
American Critical Minerals Reports High Grade Potash Intersection of 6.55m Grading 38.51 wt.% KCl at its Green River Project, Utah
-
Hemogenyx Pharmaceuticals PLC - Chairman Receives Prestigious Award
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 19
-
Bob's Watches Founder Paul Altieri Unveils Private Collection of Vintage Rolex Watches in New Book, "NOT FOR SALE"
-
Making the Most of a Long Weekend Without Leaving Town
-
Lumber's Union CBA Agent Launches in Sage Agent Marketplace to Help Simplify Union Payroll Compliance
-
Paul Scribner on General Holdings Limited's Role as a Principal Investor in Complex, Cross-Border Opportunities
-
Best Gold IRA Rollover Companies 2026 Announced: How to Choose and Gold IRA Rollover Basics Explained in New Guide
-
Remergify and Ready Set Fund Grow Launch Municipal Opportunity Zone Framework to Modernize Core Public Utilities and Bridge the Divide Between Luxury Growth and Community Stability
-
CreditRiskMonitor Trade Contributors Use New Self-Serve Feature
-
Caldwell Expands Leadership Advisory With Launch of Caldwell Leadership Intelligence
-
neoseek Builds on a Decade of Engineering Expertise to Accelerate Global Expansion in Portable Charging
-
Medical Care Technologies Inc. (OTCID:MDCE) Pauses Dilution Through 2027 After Q3 Profitability Rebound and Infinite Auctions Private Sales Exceed $300,000 in Q4
-
Route1 Announces Issuance of Shares for Compensation
-
Modular Medical Secures Coverage Agreements with All Three of the Nation's Largest PBMs for Pivot Insulin Delivery System
-
After 20 Years of Modernizing Other Companies' Software, Polcode Turns the Lens on Itself
-
Celtic Bank Selects Infinant to Scale Its Embedded Finance Programs
-
BlackBerry and Hazard Management Cayman Islands Renew Critical Alerting System for Emergencies and Public Safety
-
Long Island Capital Alliance to Host Technology Capital Forum
-
Philadelphia Sexual Assault Lawyer David P. Thiruselvam Explains Who Can Be Named in a Civil Sexual Assault Claim
How serious is Biden's prostate cancer diagnosis?
Former US president Joe Biden's prostate cancer is likely too advanced to be cured but treatment could control the spread of the disease for years, experts told AFP.
The revelation late Sunday that the 82-year-old has aggressive prostate cancer has prompted supportive statements -- as well as questions about the state of his health during his presidency and aborted re-election bid last year.
- What is the diagnosis? -
After he experienced urinary symptoms, Biden was diagnosed with prostate cancer that has spread to his bones, the ex-president's office said in a statement.
Prostate cancer is the most common cancer among men, according to the American Cancer Society.
It is particularly common in the elderly -- around 80 percent of men over 80 have some cancerous cells in their prostate gland, research has estimated.
While it is the second leading cause of cancer death in men, prostate cancer is highly treatable if discovered early.
However Biden's prostate cancer is already well advanced, having spread to his bones, meaning it has metastasised.
It is also particularly aggressive. His cancer was rated nine out of a possible 10 on the Gleason score, which ranks the aggressiveness of cancer.
To get this score, doctors take several samples -- called biopsies -- of the prostate to measure how dangerous the cancer is.
A Gleason score of nine "means that the cells look very abnormal and the cancer is likely to grow quickly", Justin Stebbing, a cancer researcher at the UK's Anglia Ruskin University, told AFP.
- Prognosis and treatment? -
Much remains unknown about Biden's condition, and the experts interviewed by AFP emphasised that they can only provide a broad outline.
Around 97 percent of men diagnosed with prostate cancer are still alive five years later.
However this rate drops to 28-33 percent when the cancer has spread to their bones, Stebbing said.
"Metastatic prostate cannot be cured," oncologist Natacha Naoun of France's Gustave-Roussy Institute told AFP. "But treatment can increase life expectancy."
Biden's statement said he is reviewing treatment options, adding that his cancer appears to be "hormone-sensitive which allows for effective management".
Stebbing said that drugs that reduce hormones such as testosterone can temporarily control the disease.
But after two or three years, "hormonal therapy stops working, and we need to think about other treatments", he added.
Chemotherapy is often an option in such cases but could pose a serious risk for a patient in his 80s.
"Maybe he's not strong enough to withstand that, or has other conditions, but this is pure speculation," Stebbing said.
Radiation therapy or surgery are other potential treatment options, depending on the nature of the cancer.
- Could this have been detected sooner? -
The ex-president's medical diagnosis could also have political repercussions.
Biden's health was already in the spotlight due to a new book detailing his declining health as he campaigned for a second presidential term against Donald Trump last year.
The revelation of such an advanced cancer in a man under such close medical scrutiny has raised the question: could signs of this disease have been detected earlier?
"Not necessarily," Stebbing said.
"Without more details, it's impossible to say... certainly a lot can happen with this type of prostate cancer in a year," he added.
Biden withdrew his re-election bid in July last year, and left the White House in January.
"We can't rule out the possibility that it was an aggressive form that developed quickly," Naoun said.
But prostate cancer is normally diagnosed earlier, she added.
"Only 10 percent of prostate cancers are diagnosed" at this metastatic stage, Naoun said.
L.Davis--AMWN